NCT04091191 is a NA clinical trial of Meta19.01 in Endometriosis, sponsored by Metagenics Europe.

Who is sponsoring NCT04091191?

NCT04091191 is sponsored by Metagenics Europe.

What drugs are being tested in NCT04091191?

Interventions in NCT04091191: Meta19.01.

What condition does NCT04091191 study?

NCT04091191 studies Endometriosis.

Is NCT04091191 still recruiting?

NCT04091191 is currently terminated. Last updated 16 March 2023.

Last reviewed 2023-03-16 · How we verify

NCT04091191

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of a Nutraceutical for Endometriosis Pain Relief

Terminated NA Last updated 16 March 2023

What this trial tests

NA trial testing Meta19.01 in Endometriosis in 5 participants. Terminated before completion.

Timeline

13 October 2021

Primary endpoint
16 December 2022

16 December 2022

Quick facts

Lead sponsor	Metagenics Europe
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	supportive care
Enrollment	5
Start date	13 October 2021
Primary completion	16 December 2022
Estimated completion	16 December 2022
Sites	1 location across Belgium

Drugs / interventions tested

Meta19.01

Conditions studied

Endometriosis — all drugs for Endometriosis →

Sponsor

Metagenics Europe

Who can join

Adults 18 to 49, female only, with Endometriosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Based on the EHP-30 questionnaire, the pain score and general well-being of all patients will be assessed with and without taking a specialized nutraceutical. These patients will be taking continuous oral contraception, for 3 months before inclusion till at least end of the study or not taking any oral contraception at all during the study due to contraindication(s).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Endometriosis

Currently open trials in the same condition.

NCT06559852 — The Impact of Yoga on Endometriosis-Related Pain · NA · recruiting
NCT07393295 — Efficacy and Tolerability of TENS in Endometriosis-related Pain · NA · recruiting
NCT07134023 — Educational Program for the Multidisciplinary Support of Patients With Endometriosis · NA · recruiting
NCT07240883 — ENDO1000 - A UK-wide Endometriosis Research Project · recruiting
NCT06974773 — Remote Electrical Stimulation as a Long-term Intervention for Endometriosis Flare Ups · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04091191 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Metagenics Europe
Last refreshed: 16 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04091191.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing